Does Diacylglycerol Accumulation in Fatty Liver Disease Cause Hepatic Insulin Resistance? - Wikidata - awgldk - TriplyDB

Does Diacylglycerol Accumulation in Fatty Liver Disease Cause Hepatic Insulin Resistance?

Does Diacylglycerol Accumulation in Fatty Liver Disease Cause Hepatic Insulin Resistance?

http://www.wikidata.org/entity/Q26798161

about

Sphingolipids and phospholipids in insulin resistance and related metabolic disorders.A multi-component classifier for nonalcoholic fatty liver disease (NAFLD) based on genomic, proteomic, and phenomic data domains.Hepatic Diacylglycerol-Associated Protein Kinase Cε Translocation Links Hepatic Steatosis to Hepatic Insulin Resistance in Humans.Disparate metabolic response to fructose feeding between different mouse strains Dietary restriction protects from age-associated DNA methylation and induces epigenetic reprogramming of lipid metabolism.Roles of Diacylglycerols and Ceramides in Hepatic Insulin Resistance.Association of muscle lipidomic profile with high-fat diet-induced insulin resistance across five mouse strains.The TIR/BB-loop mimetic AS-1 prevents non-alcoholic steatohepatitis and hepatic insulin resistance by inhibiting NLRP3-ASC inflammasome activation.Seven-Up Is a Novel Regulator of Insulin Signaling.

P2860

Q30241943-1FE3F901-F65B-49D1-BF69-E63E3D2FB314 Q31171499-65861F64-ACA5-4D59-BD3F-8B1A1A5AC7F8 Q33794679-BD87AD27-0E04-4260-BDDC-DCD4740CDFC2 Q36392668-379775E9-FFB4-425D-9423-3C9F346C65AC Q37726260-ED199140-2AB5-45A4-8DEA-7DED960473D9 Q38760082-0D739354-EEEB-40DA-A774-2EFA7FEE54F0 Q42639375-6384CC0D-73CD-45A2-9727-F712819767AE Q50673306-1DC92199-5A30-4077-9DD9-68CB484D5C7F Q52682509-7E5EBBC1-0015-4FB7-B1EA-E1088DA7A28D

P2860

Does Diacylglycerol Accumulation in Fatty Liver Disease Cause Hepatic Insulin Resistance?

http://www.wikidata.org/entity/Q26798161

description

2015 nî lūn-bûn

@nan

2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Does Diacylglycerol Accumulation in Fatty Liver Disease Cause Hepatic Insulin Resistance?

@ast

Does Diacylglycerol Accumulation in Fatty Liver Disease Cause Hepatic Insulin Resistance?

@en

Does Diacylglycerol Accumulation in Fatty Liver Disease Cause Hepatic Insulin Resistance?

@nl

type

label

Does Diacylglycerol Accumulation in Fatty Liver Disease Cause Hepatic Insulin Resistance?

@ast

Does Diacylglycerol Accumulation in Fatty Liver Disease Cause Hepatic Insulin Resistance?

@en

Does Diacylglycerol Accumulation in Fatty Liver Disease Cause Hepatic Insulin Resistance?

@nl

prefLabel

Does Diacylglycerol Accumulation in Fatty Liver Disease Cause Hepatic Insulin Resistance?

@ast

Does Diacylglycerol Accumulation in Fatty Liver Disease Cause Hepatic Insulin Resistance?

@en

Does Diacylglycerol Accumulation in Fatty Liver Disease Cause Hepatic Insulin Resistance?

@nl

P1433

Q26798161-E8B6E5C7-D3CD-452F-9AE4-875A6B5E14AB

P1476

Q26798161-26C5AC92-F133-464F-A400-2B48F27E727C

P2093

Q26798161-F7BC3CA0-9578-4606-AB71-80CF7E8234CC

P275

Q26798161-560DD050-16C6-4910-A57C-580FD153A9C3

P2860

Q26798161-044531D1-7DA4-41DE-8006-DEB1813EED16

Q26798161-064ACC3A-5F1B-497F-9032-8F9189A87F12

Q26798161-06834B6C-8C23-49B4-8CD2-13F1F59E4CFC

Q26798161-0A3E661C-0DC9-4087-8EC8-601E5ED85144

Q26798161-0DC87BA0-871D-4222-B941-040E0A284B30

Q26798161-1B3FAB7A-43B9-4E26-9DC4-F835703F744F

Q26798161-23CFF619-CB7B-4230-B5AD-0AF043C079F9

Q26798161-3BF8611D-754F-4E69-A4C5-960DEF2B6213

Q26798161-3D1931CB-67A0-45D7-9E60-9B89B936E8DF

Q26798161-419761ED-9176-46AF-92DF-7A19085C8157

P304

Q26798161-1CBD2DF4-39DF-4CA9-AF73-AA25D8D9ECD1

P31

Q26798161-8DC2EEE8-4CE0-46A5-8F60-73302E2973D9

P356

Q26798161-090FB5B0-C914-46CB-B933-C11DB91C3D32

P407

Q26798161-CC58A8F8-1235-4E0F-B42D-687577CCE74F

P478

Q26798161-17C5A074-D0B2-4416-9F75-8816BC0EFDE3

P50

Q26798161-F71DB505-E03E-46E2-9AB8-AA0EE26DE9E6

P5008

Q26798161-56675051-08D0-4F3B-8DC5-529C79CEB4F2

P577

Q26798161-50E80C55-2A04-4028-BF44-8E994CCD8E55

P5875

Q26798161-A0E35171-9414-4CB4-A10F-FBDB4274070A

P698

Q26798161-4436B617-D506-44C5-A4F7-EC82349BFE29

P921

Q26798161-2794FAA7-8945-44B6-B8F0-2095F303F417

Q26798161-5E910690-B67D-463F-8437-7F701CD151BF

Q26798161-641B6534-069D-4E69-9439-CD12A1ECE742

Q26798161-9B0E1A70-7F97-4CDD-B289-4DDEEF4618AA

Q26798161-BE035D69-D6CC-4A9B-B9A7-C100D8687E38

Q26798161-D5D58A10-2283-4110-8A7B-7B96760826FD

Q26798161-F33F01E2-DE32-4691-944A-0593169AD747

P932

Q26798161-101A0DD9-2949-4058-9315-FC36BFF3D302

P356

P1433

BioMed Research International

P1476

Does Diacylglycerol Accumulation in Fatty Liver Disease Cause Hepatic Insulin Resistance?

@en

P2093

Brian N Finck

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman Syndrome

The Saccharomyces cerevisiae Lipin homolog is a Mg2+-dependent phosphatidate phosphatase enzyme.

Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance

Three mammalian lipins act as phosphatidate phosphatases with distinct tissue expression patterns

Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease

Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance

Prevention of hepatic steatosis and hepatic insulin resistance in mitochondrial acyl-CoA:glycerol-sn-3-phosphate acyltransferase 1 knockout mice

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.

Lipin 2 is a liver-enriched phosphatidate phosphohydrolase enzyme that is dynamically regulated by fasting and obesity in mice.

Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis

P304

104132

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2015/104132

http://www.w3.org/2001/XMLSchema#string

P407

P478

2015

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2015-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281056378

http://www.w3.org/2001/XMLSchema#string

P698

26273583

http://www.w3.org/2001/XMLSchema#string

P921

fatty liver disease

physiological phenomena

P932

4529893

http://www.w3.org/2001/XMLSchema#string